Letrozole Tablets
Aromatase Inhibitor / Oncology
Letrozole Tablets
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Letrozole Tablets (Letrakast). High-quality, reliable, affordable medicine.
Formulation
Tablets
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
Finished Commercial Brand
Available finished formulation under our brand name Letrakast.
View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Letrozole Tablets
Classification: Aromatase Inhibitor / Oncology
About Letrozole Tablets
Letrozole is a non-steroidal aromatase inhibitor that prevents estrogen synthesis, widely used in hormone receptor-positive early and advanced breast cancer in postmenopausal women.
Letrozole Tablets (Letrakast) Manufactured by Aprazer Healthcare
Letrakast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.